Dementia Drugs Show Measurable Cognitive Decline Slowdown
New antibody-based medications are showing potential to address the underlying causes of Alzheimer's disease by binding to protein plaques in the brain.
New antibody-based medications are showing potential to address the underlying causes of Alzheimer's disease by binding to protein plaques in the brain. Unlike previous treatments that only stabilized patient conditions, these drugs aim to intervene in the core disease mechanism. Researchers at the University Medical Center in Greifswald are leading studies on the potential of these substances.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Source Alpha
Source Bravo
Source Charlie
Source Delta
Source Echo
Source Foxtrot
Source Golf
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade